Additional information
Yellow Powder
19685-09-7
ACI-090402
(4S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinolone-3,14(4H,12H)-dione (10-hydroxycamptothecin)
(4S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
289.2-290.0°C
C20H16N2O5
364.35
Ambient
2-8°C
(S)-10-Hydroxycamptothecin; Hydroxycamptothecin
Antineoplastic medications





![6,9-DIACYL PACLITAXEL (25 mg) ((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-Acetoxy-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,9-diyl (2R,2'R,3S,3'S)-bis(3-benzamido-2-hydroxy-3-phenylpropanoate))](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)